Roland Andersson

Papers

Total Citations

H-Index

About

Roland Andersson is a leading figure in pancreatic cancer research, with a focus on translational oncology and personalized medicine. His work centers on developing innovative preclinical models to improve therapeutic outcomes for pancreatic ductal adenocarcinoma, one of the deadliest cancers. Andersson’s most cited paper, “Organoid technology for personalized pancreatic cancer therapy” (2021, 30 citations), highlights his major contribution: advancing organoid models to mimic patient-specific tumor biology, enabling drug testing and tailored treatment strategies. This work addresses the urgent need for more effective therapies in a disease with stagnant survival rates. Beyond this, Andersson has published extensively on surgical oncology, tumor microenvironment, and biomarker discovery, with cumulative citations reflecting his influence in the field. His research bridges bench-to-bedside gaps, offering hope for better clinical management of pancreatic cancer. For students and researchers, Andersson exemplifies how integrating cutting-edge technologies like organoids can transform cancer care, making his profile a compelling study in impactful, patient-centered science.